MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Use with caution

Zyprexa 10mg tablets (Sigma Pharmaceuticals Plc)

Explore other Olanzapine formulations Explore other Olanzapine 10mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Incompatible

Zyprexa 10mg Velotabs (Abacus Medicine Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 10mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 10mg Velotabs (Eli Lilly and Company Ltd).

Incompatible

Zyprexa 10mg Velotabs (CST Pharma Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 10mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 10mg Velotabs (Eli Lilly and Company Ltd).

Incompatible

Zyprexa 10mg Velotabs (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 10mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 10mg Velotabs (Eli Lilly and Company Ltd).

Use with caution

Zyprexa 15mg tablets (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 15mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Use with caution

Zyprexa 15mg tablets (Sigma Pharmaceuticals Plc)

Explore other Olanzapine formulations Explore other Olanzapine 15mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Incompatible

Zyprexa 15mg Velotabs (CST Pharma Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 15mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility recommendation derived from Zyprexa 15mg Velotabs (Eli Lilly and Company Ltd).

Incompatible

Zyprexa 15mg Velotabs (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 15mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility recommendation derived from Zyprexa 15mg Velotabs (Eli Lilly and Company Ltd).

Use with caution

Zyprexa 2.5mg tablets (CST Pharma Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 2.5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatiblity recommendation derived from Eli Lilly and Accord Healthcare Ltd products.

Use with caution

Zyprexa 2.5mg tablets (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 2.5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatiblity recommendation derived from Eli Lilly and Accord Healthcare Ltd products.

Use with caution

Zyprexa 20mg tablets (Abacus Medicine Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 20mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Use with caution

Zyprexa 20mg tablets (CST Pharma Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 20mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Use with caution

Zyprexa 20mg tablets (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 20mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Incompatible

Zyprexa 20mg Velotabs (Abacus Medicine Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 20mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 20mg Velotabs (Eli Lilly and Company Ltd).

Incompatible

Zyprexa 20mg Velotabs (CST Pharma Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 20mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 20mg Velotabs (Eli Lilly and Company Ltd).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.